As of 2025-07-11, the Relative Valuation of TCR2 Therapeutics Inc (TCRR) is (88.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.48 USD, the upside of TCR2 Therapeutics Inc based on Relative Valuation is -6078.6%.
The range of the Relative Valuation is (58.16) - (112.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 27.2x | 20.3x |
| Forward P/E multiples | 14.0x - 30.6x | 22.3x |
| Fair Price | (58.16) - (112.99) | (88.48) |
| Upside | -4029.6% - -7734.7% | -6078.6% |
| Date | P/E |